StonvexLoading…
StonvexStonvexStonvexCore line items from GRPN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $117.20M | $498.42M | $365.71M | $242.89M |
Operating Income | $-3.32M | $23.64M | $17.13M | $14.94M |
Net Income | $-12.86M | $-83.52M | $-90.86M | $27.51M |
EPS (Diluted) | $-0.32 | $-2.08 | $-2.26 | $0.64 |
Total Assets | $595.85M | $670.41M | $608.18M | $647.40M |
Total Liabilities | $658.33M | $712.80M | $667.56M | $596.08M |
Cash & Equivalents | $225.51M | $296.08M | $238.45M | $262.57M |
Free Cash Flow OCF − CapEx | $-13.52M | $49.87M | $-3.16M | $21.43M |
Shares Outstanding | 38.84M | 40.73M | 40.75M | 40.42M |